ICD-10-CM category
T45: Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified
Codes under T45 (Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified). A ✓ marks a billable (fully specified) code; category codes without a ✓ are not billable on their own.
| Code | Description | Billable |
|---|---|---|
| T45.0 | Poisoning by, adverse effect of and underdosing of antiallergic and antiemetic drugs | — |
| T45.0 | Poisoning by, adverse effect of and underdosing of antiallergic and antiemetic drugs | — |
| T45.0X | Poisoning by, adverse effect of and underdosing of antiallergic and antiemetic drugs | — |
| T45.0X | Poisoning by, adverse effect of and underdosing of antiallergic and antiemetic drugs | — |
| T45.0X1 | Poisoning by antiallergic and antiemetic drugs, accidental (unintentional) | — |
| T45.0X1 | Poisoning by antiallergic and antiemetic drugs, accidental (unintentional) | — |
| T45.0X1A | Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter | ✓ |
| T45.0X1A | Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter | ✓ |
| T45.0X1D | Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), subsequent encounter | ✓ |
| T45.0X1D | Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), subsequent encounter | ✓ |
| T45.0X1S | Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), sequela | ✓ |
| T45.0X1S | Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), sequela | ✓ |
| T45.0X2 | Poisoning by antiallergic and antiemetic drugs, intentional self-harm | — |
| T45.0X2 | Poisoning by antiallergic and antiemetic drugs, intentional self-harm | — |
| T45.0X2A | Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter | ✓ |
| T45.0X2A | Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter | ✓ |
| T45.0X2D | Poisoning by antiallergic and antiemetic drugs, intentional self-harm, subsequent encounter | ✓ |
| T45.0X2D | Poisoning by antiallergic and antiemetic drugs, intentional self-harm, subsequent encounter | ✓ |
| T45.0X2S | Poisoning by antiallergic and antiemetic drugs, intentional self-harm, sequela | ✓ |
| T45.0X2S | Poisoning by antiallergic and antiemetic drugs, intentional self-harm, sequela | ✓ |
| T45.0X3 | Poisoning by antiallergic and antiemetic drugs, assault | — |
| T45.0X3 | Poisoning by antiallergic and antiemetic drugs, assault | — |
| T45.0X3A | Poisoning by antiallergic and antiemetic drugs, assault, initial encounter | ✓ |
| T45.0X3A | Poisoning by antiallergic and antiemetic drugs, assault, initial encounter | ✓ |
| T45.0X3D | Poisoning by antiallergic and antiemetic drugs, assault, subsequent encounter | ✓ |
| T45.0X3D | Poisoning by antiallergic and antiemetic drugs, assault, subsequent encounter | ✓ |
| T45.0X3S | Poisoning by antiallergic and antiemetic drugs, assault, sequela | ✓ |
| T45.0X3S | Poisoning by antiallergic and antiemetic drugs, assault, sequela | ✓ |
| T45.0X4 | Poisoning by antiallergic and antiemetic drugs, undetermined | — |
| T45.0X4 | Poisoning by antiallergic and antiemetic drugs, undetermined | — |
| T45.0X4A | Poisoning by antiallergic and antiemetic drugs, undetermined, initial encounter | ✓ |
| T45.0X4A | Poisoning by antiallergic and antiemetic drugs, undetermined, initial encounter | ✓ |
| T45.0X4D | Poisoning by antiallergic and antiemetic drugs, undetermined, subsequent encounter | ✓ |
| T45.0X4D | Poisoning by antiallergic and antiemetic drugs, undetermined, subsequent encounter | ✓ |
| T45.0X4S | Poisoning by antiallergic and antiemetic drugs, undetermined, sequela | ✓ |
| T45.0X4S | Poisoning by antiallergic and antiemetic drugs, undetermined, sequela | ✓ |
| T45.0X5 | Adverse effect of antiallergic and antiemetic drugs | — |
| T45.0X5 | Adverse effect of antiallergic and antiemetic drugs | — |
| T45.0X5A | Adverse effect of antiallergic and antiemetic drugs, initial encounter | ✓ |
| T45.0X5A | Adverse effect of antiallergic and antiemetic drugs, initial encounter | ✓ |
| T45.0X5D | Adverse effect of antiallergic and antiemetic drugs, subsequent encounter | ✓ |
| T45.0X5D | Adverse effect of antiallergic and antiemetic drugs, subsequent encounter | ✓ |
| T45.0X5S | Adverse effect of antiallergic and antiemetic drugs, sequela | ✓ |
| T45.0X5S | Adverse effect of antiallergic and antiemetic drugs, sequela | ✓ |
| T45.0X6 | Underdosing of antiallergic and antiemetic drugs | — |
| T45.0X6 | Underdosing of antiallergic and antiemetic drugs | — |
| T45.0X6A | Underdosing of antiallergic and antiemetic drugs, initial encounter | ✓ |
| T45.0X6A | Underdosing of antiallergic and antiemetic drugs, initial encounter | ✓ |
| T45.0X6D | Underdosing of antiallergic and antiemetic drugs, subsequent encounter | ✓ |
| T45.0X6D | Underdosing of antiallergic and antiemetic drugs, subsequent encounter | ✓ |
| T45.0X6S | Underdosing of antiallergic and antiemetic drugs, sequela | ✓ |
| T45.0X6S | Underdosing of antiallergic and antiemetic drugs, sequela | ✓ |
| T45.1 | Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs | — |
| T45.1 | Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs | — |
| T45.1X | Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs | — |
| T45.1X | Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs | — |
| T45.1X1 | Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional) | — |
| T45.1X1 | Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional) | — |
| T45.1X1A | Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter | ✓ |
| T45.1X1A | Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter | ✓ |
| T45.1X1D | Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), subsequent encounter | ✓ |
| T45.1X1D | Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), subsequent encounter | ✓ |
| T45.1X1S | Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), sequela | ✓ |
| T45.1X1S | Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), sequela | ✓ |
| T45.1X2 | Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm | — |
| T45.1X2 | Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm | — |
| T45.1X2A | Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter | ✓ |
| T45.1X2A | Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter | ✓ |
| T45.1X2D | Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, subsequent encounter | ✓ |
| T45.1X2D | Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, subsequent encounter | ✓ |
| T45.1X2S | Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, sequela | ✓ |
| T45.1X2S | Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, sequela | ✓ |
| T45.1X3 | Poisoning by antineoplastic and immunosuppressive drugs, assault | — |
| T45.1X3 | Poisoning by antineoplastic and immunosuppressive drugs, assault | — |
| T45.1X3A | Poisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter | ✓ |
| T45.1X3A | Poisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter | ✓ |
| T45.1X3D | Poisoning by antineoplastic and immunosuppressive drugs, assault, subsequent encounter | ✓ |
| T45.1X3D | Poisoning by antineoplastic and immunosuppressive drugs, assault, subsequent encounter | ✓ |
| T45.1X3S | Poisoning by antineoplastic and immunosuppressive drugs, assault, sequela | ✓ |
| T45.1X3S | Poisoning by antineoplastic and immunosuppressive drugs, assault, sequela | ✓ |
| T45.1X4 | Poisoning by antineoplastic and immunosuppressive drugs, undetermined | — |
| T45.1X4 | Poisoning by antineoplastic and immunosuppressive drugs, undetermined | — |
| T45.1X4A | Poisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter | ✓ |
| T45.1X4A | Poisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter | ✓ |
| T45.1X4D | Poisoning by antineoplastic and immunosuppressive drugs, undetermined, subsequent encounter | ✓ |
| T45.1X4D | Poisoning by antineoplastic and immunosuppressive drugs, undetermined, subsequent encounter | ✓ |
| T45.1X4S | Poisoning by antineoplastic and immunosuppressive drugs, undetermined, sequela | ✓ |
| T45.1X4S | Poisoning by antineoplastic and immunosuppressive drugs, undetermined, sequela | ✓ |
| T45.1X5 | Adverse effect of antineoplastic and immunosuppressive drugs | — |
| T45.1X5 | Adverse effect of antineoplastic and immunosuppressive drugs | — |
| T45.1X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter | ✓ |
| T45.1X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter | ✓ |
| T45.1X5D | Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | ✓ |
| T45.1X5D | Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter | ✓ |
| T45.1X5S | Adverse effect of antineoplastic and immunosuppressive drugs, sequela | ✓ |
| T45.1X5S | Adverse effect of antineoplastic and immunosuppressive drugs, sequela | ✓ |
| T45.1X6 | Underdosing of antineoplastic and immunosuppressive drugs | — |
| T45.1X6 | Underdosing of antineoplastic and immunosuppressive drugs | — |
| T45.1X6A | Underdosing of antineoplastic and immunosuppressive drugs, initial encounter | ✓ |
| T45.1X6A | Underdosing of antineoplastic and immunosuppressive drugs, initial encounter | ✓ |
| T45.1X6D | Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter | ✓ |
| T45.1X6D | Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter | ✓ |
| T45.1X6S | Underdosing of antineoplastic and immunosuppressive drugs, sequela | ✓ |
| T45.1X6S | Underdosing of antineoplastic and immunosuppressive drugs, sequela | ✓ |
| T45.2 | Poisoning by, adverse effect of and underdosing of vitamins | — |
| T45.2 | Poisoning by, adverse effect of and underdosing of vitamins | — |
| T45.2X | Poisoning by, adverse effect of and underdosing of vitamins | — |
| T45.2X | Poisoning by, adverse effect of and underdosing of vitamins | — |
| T45.2X1 | Poisoning by vitamins, accidental (unintentional) | — |
| T45.2X1 | Poisoning by vitamins, accidental (unintentional) | — |
| T45.2X1A | Poisoning by vitamins, accidental (unintentional), initial encounter | ✓ |
| T45.2X1A | Poisoning by vitamins, accidental (unintentional), initial encounter | ✓ |
| T45.2X1D | Poisoning by vitamins, accidental (unintentional), subsequent encounter | ✓ |
| T45.2X1D | Poisoning by vitamins, accidental (unintentional), subsequent encounter | ✓ |
| T45.2X1S | Poisoning by vitamins, accidental (unintentional), sequela | ✓ |
| T45.2X1S | Poisoning by vitamins, accidental (unintentional), sequela | ✓ |
| T45.2X2 | Poisoning by vitamins, intentional self-harm | — |
| T45.2X2 | Poisoning by vitamins, intentional self-harm | — |
| T45.2X2A | Poisoning by vitamins, intentional self-harm, initial encounter | ✓ |
| T45.2X2A | Poisoning by vitamins, intentional self-harm, initial encounter | ✓ |
| T45.2X2D | Poisoning by vitamins, intentional self-harm, subsequent encounter | ✓ |
| T45.2X2D | Poisoning by vitamins, intentional self-harm, subsequent encounter | ✓ |
| T45.2X2S | Poisoning by vitamins, intentional self-harm, sequela | ✓ |
| T45.2X2S | Poisoning by vitamins, intentional self-harm, sequela | ✓ |
| T45.2X3 | Poisoning by vitamins, assault | — |
| T45.2X3 | Poisoning by vitamins, assault | — |
| T45.2X3A | Poisoning by vitamins, assault, initial encounter | ✓ |
| T45.2X3A | Poisoning by vitamins, assault, initial encounter | ✓ |
| T45.2X3D | Poisoning by vitamins, assault, subsequent encounter | ✓ |
| T45.2X3D | Poisoning by vitamins, assault, subsequent encounter | ✓ |
| T45.2X3S | Poisoning by vitamins, assault, sequela | ✓ |
| T45.2X3S | Poisoning by vitamins, assault, sequela | ✓ |
| T45.2X4 | Poisoning by vitamins, undetermined | — |
| T45.2X4 | Poisoning by vitamins, undetermined | — |
| T45.2X4A | Poisoning by vitamins, undetermined, initial encounter | ✓ |
| T45.2X4A | Poisoning by vitamins, undetermined, initial encounter | ✓ |
| T45.2X4D | Poisoning by vitamins, undetermined, subsequent encounter | ✓ |
| T45.2X4D | Poisoning by vitamins, undetermined, subsequent encounter | ✓ |
| T45.2X4S | Poisoning by vitamins, undetermined, sequela | ✓ |
| T45.2X4S | Poisoning by vitamins, undetermined, sequela | ✓ |
| T45.2X5 | Adverse effect of vitamins | — |
| T45.2X5 | Adverse effect of vitamins | — |
| T45.2X5A | Adverse effect of vitamins, initial encounter | ✓ |
| T45.2X5A | Adverse effect of vitamins, initial encounter | ✓ |
| T45.2X5D | Adverse effect of vitamins, subsequent encounter | ✓ |
| T45.2X5D | Adverse effect of vitamins, subsequent encounter | ✓ |
| T45.2X5S | Adverse effect of vitamins, sequela | ✓ |
| T45.2X5S | Adverse effect of vitamins, sequela | ✓ |
| T45.2X6 | Underdosing of vitamins | — |
| T45.2X6 | Underdosing of vitamins | — |
| T45.2X6A | Underdosing of vitamins, initial encounter | ✓ |
| T45.2X6A | Underdosing of vitamins, initial encounter | ✓ |
| T45.2X6D | Underdosing of vitamins, subsequent encounter | ✓ |
| T45.2X6D | Underdosing of vitamins, subsequent encounter | ✓ |
| T45.2X6S | Underdosing of vitamins, sequela | ✓ |
| T45.2X6S | Underdosing of vitamins, sequela | ✓ |
| T45.3 | Poisoning by, adverse effect of and underdosing of enzymes | — |
| T45.3 | Poisoning by, adverse effect of and underdosing of enzymes | — |
| T45.3X | Poisoning by, adverse effect of and underdosing of enzymes | — |
| T45.3X | Poisoning by, adverse effect of and underdosing of enzymes | — |
| T45.3X1 | Poisoning by enzymes, accidental (unintentional) | — |
| T45.3X1 | Poisoning by enzymes, accidental (unintentional) | — |
| T45.3X1A | Poisoning by enzymes, accidental (unintentional), initial encounter | ✓ |
| T45.3X1A | Poisoning by enzymes, accidental (unintentional), initial encounter | ✓ |
| T45.3X1D | Poisoning by enzymes, accidental (unintentional), subsequent encounter | ✓ |
| T45.3X1D | Poisoning by enzymes, accidental (unintentional), subsequent encounter | ✓ |
| T45.3X1S | Poisoning by enzymes, accidental (unintentional), sequela | ✓ |
| T45.3X1S | Poisoning by enzymes, accidental (unintentional), sequela | ✓ |
| T45.3X2 | Poisoning by enzymes, intentional self-harm | — |
| T45.3X2 | Poisoning by enzymes, intentional self-harm | — |
| T45.3X2A | Poisoning by enzymes, intentional self-harm, initial encounter | ✓ |
| T45.3X2A | Poisoning by enzymes, intentional self-harm, initial encounter | ✓ |
| T45.3X2D | Poisoning by enzymes, intentional self-harm, subsequent encounter | ✓ |
| T45.3X2D | Poisoning by enzymes, intentional self-harm, subsequent encounter | ✓ |
| T45.3X2S | Poisoning by enzymes, intentional self-harm, sequela | ✓ |
| T45.3X2S | Poisoning by enzymes, intentional self-harm, sequela | ✓ |
| T45.3X3 | Poisoning by enzymes, assault | — |
| T45.3X3 | Poisoning by enzymes, assault | — |
| T45.3X3A | Poisoning by enzymes, assault, initial encounter | ✓ |
| T45.3X3A | Poisoning by enzymes, assault, initial encounter | ✓ |
| T45.3X3D | Poisoning by enzymes, assault, subsequent encounter | ✓ |
| T45.3X3D | Poisoning by enzymes, assault, subsequent encounter | ✓ |
| T45.3X3S | Poisoning by enzymes, assault, sequela | ✓ |
| T45.3X3S | Poisoning by enzymes, assault, sequela | ✓ |
| T45.3X4 | Poisoning by enzymes, undetermined | — |
| T45.3X4 | Poisoning by enzymes, undetermined | — |
| T45.3X4A | Poisoning by enzymes, undetermined, initial encounter | ✓ |
| T45.3X4A | Poisoning by enzymes, undetermined, initial encounter | ✓ |
| T45.3X4D | Poisoning by enzymes, undetermined, subsequent encounter | ✓ |
| T45.3X4D | Poisoning by enzymes, undetermined, subsequent encounter | ✓ |
| T45.3X4S | Poisoning by enzymes, undetermined, sequela | ✓ |
| T45.3X4S | Poisoning by enzymes, undetermined, sequela | ✓ |
| T45.3X5 | Adverse effect of enzymes | — |
| T45.3X5 | Adverse effect of enzymes | — |
| T45.3X5A | Adverse effect of enzymes, initial encounter | ✓ |
| T45.3X5A | Adverse effect of enzymes, initial encounter | ✓ |
| T45.3X5D | Adverse effect of enzymes, subsequent encounter | ✓ |
| T45.3X5D | Adverse effect of enzymes, subsequent encounter | ✓ |
| T45.3X5S | Adverse effect of enzymes, sequela | ✓ |
| T45.3X5S | Adverse effect of enzymes, sequela | ✓ |
| T45.3X6 | Underdosing of enzymes | — |
| T45.3X6 | Underdosing of enzymes | — |
| T45.3X6A | Underdosing of enzymes, initial encounter | ✓ |
| T45.3X6A | Underdosing of enzymes, initial encounter | ✓ |
| T45.3X6D | Underdosing of enzymes, subsequent encounter | ✓ |
| T45.3X6D | Underdosing of enzymes, subsequent encounter | ✓ |
| T45.3X6S | Underdosing of enzymes, sequela | ✓ |
| T45.3X6S | Underdosing of enzymes, sequela | ✓ |
| T45.4 | Poisoning by, adverse effect of and underdosing of iron and its compounds | — |
| T45.4 | Poisoning by, adverse effect of and underdosing of iron and its compounds | — |
| T45.4X | Poisoning by, adverse effect of and underdosing of iron and its compounds | — |
| T45.4X | Poisoning by, adverse effect of and underdosing of iron and its compounds | — |
| T45.4X1 | Poisoning by iron and its compounds, accidental (unintentional) | — |
| T45.4X1 | Poisoning by iron and its compounds, accidental (unintentional) | — |
| T45.4X1A | Poisoning by iron and its compounds, accidental (unintentional), initial encounter | ✓ |
| T45.4X1A | Poisoning by iron and its compounds, accidental (unintentional), initial encounter | ✓ |
| T45.4X1D | Poisoning by iron and its compounds, accidental (unintentional), subsequent encounter | ✓ |
| T45.4X1D | Poisoning by iron and its compounds, accidental (unintentional), subsequent encounter | ✓ |
| T45.4X1S | Poisoning by iron and its compounds, accidental (unintentional), sequela | ✓ |
| T45.4X1S | Poisoning by iron and its compounds, accidental (unintentional), sequela | ✓ |
| T45.4X2 | Poisoning by iron and its compounds, intentional self-harm | — |
| T45.4X2 | Poisoning by iron and its compounds, intentional self-harm | — |
| T45.4X2A | Poisoning by iron and its compounds, intentional self-harm, initial encounter | ✓ |
| T45.4X2A | Poisoning by iron and its compounds, intentional self-harm, initial encounter | ✓ |
| T45.4X2D | Poisoning by iron and its compounds, intentional self-harm, subsequent encounter | ✓ |
| T45.4X2D | Poisoning by iron and its compounds, intentional self-harm, subsequent encounter | ✓ |
| T45.4X2S | Poisoning by iron and its compounds, intentional self-harm, sequela | ✓ |
| T45.4X2S | Poisoning by iron and its compounds, intentional self-harm, sequela | ✓ |
| T45.4X3 | Poisoning by iron and its compounds, assault | — |
| T45.4X3 | Poisoning by iron and its compounds, assault | — |
| T45.4X3A | Poisoning by iron and its compounds, assault, initial encounter | ✓ |
| T45.4X3A | Poisoning by iron and its compounds, assault, initial encounter | ✓ |
| T45.4X3D | Poisoning by iron and its compounds, assault, subsequent encounter | ✓ |
| T45.4X3D | Poisoning by iron and its compounds, assault, subsequent encounter | ✓ |
| T45.4X3S | Poisoning by iron and its compounds, assault, sequela | ✓ |
| T45.4X3S | Poisoning by iron and its compounds, assault, sequela | ✓ |
| T45.4X4 | Poisoning by iron and its compounds, undetermined | — |
| T45.4X4 | Poisoning by iron and its compounds, undetermined | — |
| T45.4X4A | Poisoning by iron and its compounds, undetermined, initial encounter | ✓ |
| T45.4X4A | Poisoning by iron and its compounds, undetermined, initial encounter | ✓ |
| T45.4X4D | Poisoning by iron and its compounds, undetermined, subsequent encounter | ✓ |
| T45.4X4D | Poisoning by iron and its compounds, undetermined, subsequent encounter | ✓ |
| T45.4X4S | Poisoning by iron and its compounds, undetermined, sequela | ✓ |
| T45.4X4S | Poisoning by iron and its compounds, undetermined, sequela | ✓ |
| T45.4X5 | Adverse effect of iron and its compounds | — |
| T45.4X5 | Adverse effect of iron and its compounds | — |
| T45.4X5A | Adverse effect of iron and its compounds, initial encounter | ✓ |
| T45.4X5A | Adverse effect of iron and its compounds, initial encounter | ✓ |
| T45.4X5D | Adverse effect of iron and its compounds, subsequent encounter | ✓ |
| T45.4X5D | Adverse effect of iron and its compounds, subsequent encounter | ✓ |
| T45.4X5S | Adverse effect of iron and its compounds, sequela | ✓ |
| T45.4X5S | Adverse effect of iron and its compounds, sequela | ✓ |
| T45.4X6 | Underdosing of iron and its compounds | — |
| T45.4X6 | Underdosing of iron and its compounds | — |
| T45.4X6A | Underdosing of iron and its compounds, initial encounter | ✓ |
| T45.4X6A | Underdosing of iron and its compounds, initial encounter | ✓ |
| T45.4X6D | Underdosing of iron and its compounds, subsequent encounter | ✓ |
| T45.4X6D | Underdosing of iron and its compounds, subsequent encounter | ✓ |
| T45.4X6S | Underdosing of iron and its compounds, sequela | ✓ |
| T45.4X6S | Underdosing of iron and its compounds, sequela | ✓ |
| T45.5 | Poisoning by, adverse effect of and underdosing of anticoagulants and antithrombotic drugs | — |
| T45.5 | Poisoning by, adverse effect of and underdosing of anticoagulants and antithrombotic drugs | — |
| T45.6 | Poisoning by, adverse effect of and underdosing of fibrinolysis-affecting drugs | — |
| T45.6 | Poisoning by, adverse effect of and underdosing of fibrinolysis-affecting drugs | — |
| T45.7 | Poisoning by, adverse effect of and underdosing of anticoagulant antagonists, vitamin K and other coagulants | — |
| T45.7 | Poisoning by, adverse effect of and underdosing of anticoagulant antagonists, vitamin K and other coagulants | — |
| T45.7X | Poisoning by, adverse effect of and underdosing of anticoagulant antagonists, vitamin K and other coagulants | — |
| T45.7X | Poisoning by, adverse effect of and underdosing of anticoagulant antagonists, vitamin K and other coagulants | — |
| T45.7X1 | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional) | — |
| T45.7X1 | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional) | — |
| T45.7X1A | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter | ✓ |
| T45.7X1A | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter | ✓ |
| T45.7X1D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), subsequent encounter | ✓ |
| T45.7X1D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), subsequent encounter | ✓ |
| T45.7X1S | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela | ✓ |
| T45.7X1S | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela | ✓ |
| T45.7X2 | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm | — |
| T45.7X2 | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm | — |
| T45.7X2A | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter | ✓ |
| T45.7X2A | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter | ✓ |
| T45.7X2D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter | ✓ |
| T45.7X2D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter | ✓ |
| T45.7X2S | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela | ✓ |
| T45.7X2S | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela | ✓ |
| T45.7X3 | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault | — |
| T45.7X3 | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault | — |
| T45.7X3A | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter | ✓ |
| T45.7X3A | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter | ✓ |
| T45.7X3D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter | ✓ |
| T45.7X3D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter | ✓ |
| T45.7X3S | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela | ✓ |
| T45.7X3S | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela | ✓ |
| T45.7X4 | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined | — |
| T45.7X4 | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined | — |
| T45.7X4A | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter | ✓ |
| T45.7X4A | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter | ✓ |
| T45.7X4D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter | ✓ |
| T45.7X4D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter | ✓ |
| T45.7X4S | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela | ✓ |
| T45.7X4S | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela | ✓ |
| T45.7X5 | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants | — |
| T45.7X5 | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants | — |
| T45.7X5A | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter | ✓ |
| T45.7X5A | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter | ✓ |
| T45.7X5D | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter | ✓ |
| T45.7X5D | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter | ✓ |
| T45.7X5S | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela | ✓ |
| T45.7X5S | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela | ✓ |
| T45.7X6 | Underdosing of anticoagulant antagonist, vitamin K and other coagulants | — |
| T45.7X6 | Underdosing of anticoagulant antagonist, vitamin K and other coagulants | — |
| T45.7X6A | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter | ✓ |
| T45.7X6A | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter | ✓ |
| T45.7X6D | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter | ✓ |
| T45.7X6D | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter | ✓ |
| T45.7X6S | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela | ✓ |
| T45.7X6S | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela | ✓ |
| T45.8 | Poisoning by, adverse effect of and underdosing of other primarily systemic and hematological agents | — |
| T45.8 | Poisoning by, adverse effect of and underdosing of other primarily systemic and hematological agents | — |
| T45.8X | Poisoning by, adverse effect of and underdosing of other primarily systemic and hematological agents | — |
| T45.8X | Poisoning by, adverse effect of and underdosing of other primarily systemic and hematological agents | — |
| T45.8X1 | Poisoning by other primarily systemic and hematological agents, accidental (unintentional) | — |
| T45.8X1 | Poisoning by other primarily systemic and hematological agents, accidental (unintentional) | — |
| T45.8X1A | Poisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter | ✓ |
| T45.8X1A | Poisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter | ✓ |
| T45.8X1D | Poisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter | ✓ |
| T45.8X1D | Poisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter | ✓ |
| T45.8X1S | Poisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela | ✓ |
| T45.8X1S | Poisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela | ✓ |
| T45.8X2 | Poisoning by other primarily systemic and hematological agents, intentional self-harm | — |
| T45.8X2 | Poisoning by other primarily systemic and hematological agents, intentional self-harm | — |
| T45.8X2A | Poisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter | ✓ |
| T45.8X2A | Poisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter | ✓ |
| T45.8X2D | Poisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter | ✓ |
| T45.8X2D | Poisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter | ✓ |
| T45.8X2S | Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela | ✓ |
| T45.8X2S | Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela | ✓ |
| T45.8X3 | Poisoning by other primarily systemic and hematological agents, assault | — |
| T45.8X3 | Poisoning by other primarily systemic and hematological agents, assault | — |
| T45.8X3A | Poisoning by other primarily systemic and hematological agents, assault, initial encounter | ✓ |
| T45.8X3A | Poisoning by other primarily systemic and hematological agents, assault, initial encounter | ✓ |
| T45.8X3D | Poisoning by other primarily systemic and hematological agents, assault, subsequent encounter | ✓ |
| T45.8X3D | Poisoning by other primarily systemic and hematological agents, assault, subsequent encounter | ✓ |
| T45.8X3S | Poisoning by other primarily systemic and hematological agents, assault, sequela | ✓ |
| T45.8X3S | Poisoning by other primarily systemic and hematological agents, assault, sequela | ✓ |
| T45.8X4 | Poisoning by other primarily systemic and hematological agents, undetermined | — |
| T45.8X4 | Poisoning by other primarily systemic and hematological agents, undetermined | — |
| T45.8X4A | Poisoning by other primarily systemic and hematological agents, undetermined, initial encounter | ✓ |
| T45.8X4A | Poisoning by other primarily systemic and hematological agents, undetermined, initial encounter | ✓ |
| T45.8X4D | Poisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter | ✓ |
| T45.8X4D | Poisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter | ✓ |
| T45.8X4S | Poisoning by other primarily systemic and hematological agents, undetermined, sequela | ✓ |
| T45.8X4S | Poisoning by other primarily systemic and hematological agents, undetermined, sequela | ✓ |
| T45.8X5 | Adverse effect of other primarily systemic and hematological agents | — |
| T45.8X5 | Adverse effect of other primarily systemic and hematological agents | — |
| T45.8X5A | Adverse effect of other primarily systemic and hematological agents, initial encounter | ✓ |
| T45.8X5A | Adverse effect of other primarily systemic and hematological agents, initial encounter | ✓ |
| T45.8X5D | Adverse effect of other primarily systemic and hematological agents, subsequent encounter | ✓ |
| T45.8X5D | Adverse effect of other primarily systemic and hematological agents, subsequent encounter | ✓ |
| T45.8X5S | Adverse effect of other primarily systemic and hematological agents, sequela | ✓ |
| T45.8X5S | Adverse effect of other primarily systemic and hematological agents, sequela | ✓ |
| T45.8X6 | Underdosing of other primarily systemic and hematological agents | — |
| T45.8X6 | Underdosing of other primarily systemic and hematological agents | — |
| T45.8X6A | Underdosing of other primarily systemic and hematological agents, initial encounter | ✓ |
| T45.8X6A | Underdosing of other primarily systemic and hematological agents, initial encounter | ✓ |
| T45.8X6D | Underdosing of other primarily systemic and hematological agents, subsequent encounter | ✓ |
| T45.8X6D | Underdosing of other primarily systemic and hematological agents, subsequent encounter | ✓ |
| T45.8X6S | Underdosing of other primarily systemic and hematological agents, sequela | ✓ |
| T45.8X6S | Underdosing of other primarily systemic and hematological agents, sequela | ✓ |
| T45.9 | Poisoning by, adverse effect of and underdosing of unspecified primarily systemic and hematological agent | — |
| T45.9 | Poisoning by, adverse effect of and underdosing of unspecified primarily systemic and hematological agent | — |
| T45.51 | Poisoning by, adverse effect of and underdosing of anticoagulants | — |
| T45.51 | Poisoning by, adverse effect of and underdosing of anticoagulants | — |
| T45.52 | Poisoning by, adverse effect of and underdosing of antithrombotic drugs | — |
| T45.52 | Poisoning by, adverse effect of and underdosing of antithrombotic drugs | — |
| T45.60 | Poisoning by, adverse effect of and underdosing of unspecified fibrinolysis-affecting drugs | — |
| T45.60 | Poisoning by, adverse effect of and underdosing of unspecified fibrinolysis-affecting drugs | — |
| T45.61 | Poisoning by, adverse effect of and underdosing of thrombolytic drugs | — |
| T45.61 | Poisoning by, adverse effect of and underdosing of thrombolytic drugs | — |
| T45.62 | Poisoning by, adverse effect of and underdosing of hemostatic drugs | — |
| T45.62 | Poisoning by, adverse effect of and underdosing of hemostatic drugs | — |
| T45.69 | Poisoning by, adverse effect of and underdosing of other fibrinolysis-affecting drugs | — |
| T45.69 | Poisoning by, adverse effect of and underdosing of other fibrinolysis-affecting drugs | — |
| T45.91 | Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional) | — |
| T45.91 | Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional) | — |
| T45.91XA | Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter | ✓ |
| T45.91XA | Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter | ✓ |
| T45.91XD | Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter | ✓ |
| T45.91XD | Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter | ✓ |
| T45.91XS | Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela | ✓ |
| T45.91XS | Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela | ✓ |
| T45.92 | Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm | — |
| T45.92 | Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm | — |
| T45.92XA | Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter | ✓ |
| T45.92XA | Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter | ✓ |
| T45.92XD | Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter | ✓ |
| T45.92XD | Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter | ✓ |
| T45.92XS | Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela | ✓ |
| T45.92XS | Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela | ✓ |
| T45.93 | Poisoning by unspecified primarily systemic and hematological agent, assault | — |
| T45.93 | Poisoning by unspecified primarily systemic and hematological agent, assault | — |
| T45.93XA | Poisoning by unspecified primarily systemic and hematological agent, assault, initial encounter | ✓ |
| T45.93XA | Poisoning by unspecified primarily systemic and hematological agent, assault, initial encounter | ✓ |
| T45.93XD | Poisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter | ✓ |
| T45.93XD | Poisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter | ✓ |
| T45.93XS | Poisoning by unspecified primarily systemic and hematological agent, assault, sequela | ✓ |
| T45.93XS | Poisoning by unspecified primarily systemic and hematological agent, assault, sequela | ✓ |
| T45.94 | Poisoning by unspecified primarily systemic and hematological agent, undetermined | — |
| T45.94 | Poisoning by unspecified primarily systemic and hematological agent, undetermined | — |
| T45.94XA | Poisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter | ✓ |
| T45.94XA | Poisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter | ✓ |
| T45.94XD | Poisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter | ✓ |
| T45.94XD | Poisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter | ✓ |
| T45.94XS | Poisoning by unspecified primarily systemic and hematological agent, undetermined, sequela | ✓ |
| T45.94XS | Poisoning by unspecified primarily systemic and hematological agent, undetermined, sequela | ✓ |
| T45.95 | Adverse effect of unspecified primarily systemic and hematological agent | — |
| T45.95 | Adverse effect of unspecified primarily systemic and hematological agent | — |
| T45.95XA | Adverse effect of unspecified primarily systemic and hematological agent, initial encounter | ✓ |
| T45.95XA | Adverse effect of unspecified primarily systemic and hematological agent, initial encounter | ✓ |
| T45.95XD | Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter | ✓ |
| T45.95XD | Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter | ✓ |
| T45.95XS | Adverse effect of unspecified primarily systemic and hematological agent, sequela | ✓ |
| T45.95XS | Adverse effect of unspecified primarily systemic and hematological agent, sequela | ✓ |
| T45.96 | Underdosing of unspecified primarily systemic and hematological agent | — |
| T45.96 | Underdosing of unspecified primarily systemic and hematological agent | — |
| T45.96XA | Underdosing of unspecified primarily systemic and hematological agent, initial encounter | ✓ |
| T45.96XA | Underdosing of unspecified primarily systemic and hematological agent, initial encounter | ✓ |
| T45.96XD | Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter | ✓ |
| T45.96XD | Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter | ✓ |
| T45.96XS | Underdosing of unspecified primarily systemic and hematological agent, sequela | ✓ |
| T45.96XS | Underdosing of unspecified primarily systemic and hematological agent, sequela | ✓ |
| T45.511 | Poisoning by anticoagulants, accidental (unintentional) | — |
| T45.511 | Poisoning by anticoagulants, accidental (unintentional) | — |
| T45.511A | Poisoning by anticoagulants, accidental (unintentional), initial encounter | ✓ |
| T45.511A | Poisoning by anticoagulants, accidental (unintentional), initial encounter | ✓ |
| T45.511D | Poisoning by anticoagulants, accidental (unintentional), subsequent encounter | ✓ |
| T45.511D | Poisoning by anticoagulants, accidental (unintentional), subsequent encounter | ✓ |
| T45.511S | Poisoning by anticoagulants, accidental (unintentional), sequela | ✓ |
| T45.511S | Poisoning by anticoagulants, accidental (unintentional), sequela | ✓ |
| T45.512 | Poisoning by anticoagulants, intentional self-harm | — |
| T45.512 | Poisoning by anticoagulants, intentional self-harm | — |
| T45.512A | Poisoning by anticoagulants, intentional self-harm, initial encounter | ✓ |
| T45.512A | Poisoning by anticoagulants, intentional self-harm, initial encounter | ✓ |
| T45.512D | Poisoning by anticoagulants, intentional self-harm, subsequent encounter | ✓ |
| T45.512D | Poisoning by anticoagulants, intentional self-harm, subsequent encounter | ✓ |
| T45.512S | Poisoning by anticoagulants, intentional self-harm, sequela | ✓ |
| T45.512S | Poisoning by anticoagulants, intentional self-harm, sequela | ✓ |
| T45.513 | Poisoning by anticoagulants, assault | — |
| T45.513 | Poisoning by anticoagulants, assault | — |
| T45.513A | Poisoning by anticoagulants, assault, initial encounter | ✓ |
| T45.513A | Poisoning by anticoagulants, assault, initial encounter | ✓ |
| T45.513D | Poisoning by anticoagulants, assault, subsequent encounter | ✓ |
| T45.513D | Poisoning by anticoagulants, assault, subsequent encounter | ✓ |
| T45.513S | Poisoning by anticoagulants, assault, sequela | ✓ |
| T45.513S | Poisoning by anticoagulants, assault, sequela | ✓ |
| T45.514 | Poisoning by anticoagulants, undetermined | — |
| T45.514 | Poisoning by anticoagulants, undetermined | — |
| T45.514A | Poisoning by anticoagulants, undetermined, initial encounter | ✓ |
| T45.514A | Poisoning by anticoagulants, undetermined, initial encounter | ✓ |
| T45.514D | Poisoning by anticoagulants, undetermined, subsequent encounter | ✓ |
| T45.514D | Poisoning by anticoagulants, undetermined, subsequent encounter | ✓ |
| T45.514S | Poisoning by anticoagulants, undetermined, sequela | ✓ |
| T45.514S | Poisoning by anticoagulants, undetermined, sequela | ✓ |
| T45.515 | Adverse effect of anticoagulants | — |
| T45.515 | Adverse effect of anticoagulants | — |
| T45.515A | Adverse effect of anticoagulants, initial encounter | ✓ |
| T45.515A | Adverse effect of anticoagulants, initial encounter | ✓ |
| T45.515D | Adverse effect of anticoagulants, subsequent encounter | ✓ |
| T45.515D | Adverse effect of anticoagulants, subsequent encounter | ✓ |
| T45.515S | Adverse effect of anticoagulants, sequela | ✓ |
| T45.515S | Adverse effect of anticoagulants, sequela | ✓ |
| T45.516 | Underdosing of anticoagulants | — |
| T45.516 | Underdosing of anticoagulants | — |
| T45.516A | Underdosing of anticoagulants, initial encounter | ✓ |
| T45.516A | Underdosing of anticoagulants, initial encounter | ✓ |
| T45.516D | Underdosing of anticoagulants, subsequent encounter | ✓ |
| T45.516D | Underdosing of anticoagulants, subsequent encounter | ✓ |
| T45.516S | Underdosing of anticoagulants, sequela | ✓ |
| T45.516S | Underdosing of anticoagulants, sequela | ✓ |
| T45.521 | Poisoning by antithrombotic drugs, accidental (unintentional) | — |
| T45.521 | Poisoning by antithrombotic drugs, accidental (unintentional) | — |
| T45.521A | Poisoning by antithrombotic drugs, accidental (unintentional), initial encounter | ✓ |
| T45.521A | Poisoning by antithrombotic drugs, accidental (unintentional), initial encounter | ✓ |
| T45.521D | Poisoning by antithrombotic drugs, accidental (unintentional), subsequent encounter | ✓ |
| T45.521D | Poisoning by antithrombotic drugs, accidental (unintentional), subsequent encounter | ✓ |
| T45.521S | Poisoning by antithrombotic drugs, accidental (unintentional), sequela | ✓ |
| T45.521S | Poisoning by antithrombotic drugs, accidental (unintentional), sequela | ✓ |
| T45.522 | Poisoning by antithrombotic drugs, intentional self-harm | — |
| T45.522 | Poisoning by antithrombotic drugs, intentional self-harm | — |
| T45.522A | Poisoning by antithrombotic drugs, intentional self-harm, initial encounter | ✓ |
| T45.522A | Poisoning by antithrombotic drugs, intentional self-harm, initial encounter | ✓ |
| T45.522D | Poisoning by antithrombotic drugs, intentional self-harm, subsequent encounter | ✓ |
| T45.522D | Poisoning by antithrombotic drugs, intentional self-harm, subsequent encounter | ✓ |
| T45.522S | Poisoning by antithrombotic drugs, intentional self-harm, sequela | ✓ |
| T45.522S | Poisoning by antithrombotic drugs, intentional self-harm, sequela | ✓ |
| T45.523 | Poisoning by antithrombotic drugs, assault | — |
| T45.523 | Poisoning by antithrombotic drugs, assault | — |
| T45.523A | Poisoning by antithrombotic drugs, assault, initial encounter | ✓ |
| T45.523A | Poisoning by antithrombotic drugs, assault, initial encounter | ✓ |
| T45.523D | Poisoning by antithrombotic drugs, assault, subsequent encounter | ✓ |
| T45.523D | Poisoning by antithrombotic drugs, assault, subsequent encounter | ✓ |
| T45.523S | Poisoning by antithrombotic drugs, assault, sequela | ✓ |
| T45.523S | Poisoning by antithrombotic drugs, assault, sequela | ✓ |
| T45.524 | Poisoning by antithrombotic drugs, undetermined | — |
| T45.524 | Poisoning by antithrombotic drugs, undetermined | — |
| T45.524A | Poisoning by antithrombotic drugs, undetermined, initial encounter | ✓ |
| T45.524A | Poisoning by antithrombotic drugs, undetermined, initial encounter | ✓ |
| T45.524D | Poisoning by antithrombotic drugs, undetermined, subsequent encounter | ✓ |
| T45.524D | Poisoning by antithrombotic drugs, undetermined, subsequent encounter | ✓ |
| T45.524S | Poisoning by antithrombotic drugs, undetermined, sequela | ✓ |
| T45.524S | Poisoning by antithrombotic drugs, undetermined, sequela | ✓ |
| T45.525 | Adverse effect of antithrombotic drugs | — |
| T45.525 | Adverse effect of antithrombotic drugs | — |
| T45.525A | Adverse effect of antithrombotic drugs, initial encounter | ✓ |
| T45.525A | Adverse effect of antithrombotic drugs, initial encounter | ✓ |
| T45.525D | Adverse effect of antithrombotic drugs, subsequent encounter | ✓ |
| T45.525D | Adverse effect of antithrombotic drugs, subsequent encounter | ✓ |
| T45.525S | Adverse effect of antithrombotic drugs, sequela | ✓ |
| T45.525S | Adverse effect of antithrombotic drugs, sequela | ✓ |
| T45.526 | Underdosing of antithrombotic drugs | — |
| T45.526 | Underdosing of antithrombotic drugs | — |
| T45.526A | Underdosing of antithrombotic drugs, initial encounter | ✓ |
| T45.526A | Underdosing of antithrombotic drugs, initial encounter | ✓ |
| T45.526D | Underdosing of antithrombotic drugs, subsequent encounter | ✓ |
| T45.526D | Underdosing of antithrombotic drugs, subsequent encounter | ✓ |
| T45.526S | Underdosing of antithrombotic drugs, sequela | ✓ |
| T45.526S | Underdosing of antithrombotic drugs, sequela | ✓ |
| T45.601 | Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional) | — |
| T45.601 | Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional) | — |
| T45.601A | Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), initial encounter | ✓ |
| T45.601A | Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), initial encounter | ✓ |
| T45.601D | Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter | ✓ |
| T45.601D | Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter | ✓ |
| T45.601S | Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), sequela | ✓ |
| T45.601S | Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), sequela | ✓ |
| T45.602 | Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm | — |
| T45.602 | Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm | — |
| T45.602A | Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, initial encounter | ✓ |
| T45.602A | Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, initial encounter | ✓ |
| T45.602D | Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter | ✓ |
| T45.602D | Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter | ✓ |
| T45.602S | Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, sequela | ✓ |
| T45.602S | Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, sequela | ✓ |
| T45.603 | Poisoning by unspecified fibrinolysis-affecting drugs, assault | — |
| T45.603 | Poisoning by unspecified fibrinolysis-affecting drugs, assault | — |
| T45.603A | Poisoning by unspecified fibrinolysis-affecting drugs, assault, initial encounter | ✓ |
| T45.603A | Poisoning by unspecified fibrinolysis-affecting drugs, assault, initial encounter | ✓ |
| T45.603D | Poisoning by unspecified fibrinolysis-affecting drugs, assault, subsequent encounter | ✓ |
| T45.603D | Poisoning by unspecified fibrinolysis-affecting drugs, assault, subsequent encounter | ✓ |
| T45.603S | Poisoning by unspecified fibrinolysis-affecting drugs, assault, sequela | ✓ |
| T45.603S | Poisoning by unspecified fibrinolysis-affecting drugs, assault, sequela | ✓ |
| T45.604 | Poisoning by unspecified fibrinolysis-affecting drugs, undetermined | — |
| T45.604 | Poisoning by unspecified fibrinolysis-affecting drugs, undetermined | — |
| T45.604A | Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, initial encounter | ✓ |
| T45.604A | Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, initial encounter | ✓ |
| T45.604D | Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, subsequent encounter | ✓ |
| T45.604D | Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, subsequent encounter | ✓ |
| T45.604S | Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, sequela | ✓ |
| T45.604S | Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, sequela | ✓ |
| T45.605 | Adverse effect of unspecified fibrinolysis-affecting drugs | — |
| T45.605 | Adverse effect of unspecified fibrinolysis-affecting drugs | — |
| T45.605A | Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter | ✓ |
| T45.605A | Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter | ✓ |
| T45.605D | Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter | ✓ |
| T45.605D | Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter | ✓ |
| T45.605S | Adverse effect of unspecified fibrinolysis-affecting drugs, sequela | ✓ |
| T45.605S | Adverse effect of unspecified fibrinolysis-affecting drugs, sequela | ✓ |
| T45.606 | Underdosing of unspecified fibrinolysis-affecting drugs | — |
| T45.606 | Underdosing of unspecified fibrinolysis-affecting drugs | — |
| T45.606A | Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter | ✓ |
| T45.606A | Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter | ✓ |
| T45.606D | Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter | ✓ |
| T45.606D | Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter | ✓ |
| T45.606S | Underdosing of unspecified fibrinolysis-affecting drugs, sequela | ✓ |
| T45.606S | Underdosing of unspecified fibrinolysis-affecting drugs, sequela | ✓ |
| T45.611 | Poisoning by thrombolytic drug, accidental (unintentional) | — |
| T45.611 | Poisoning by thrombolytic drug, accidental (unintentional) | — |
| T45.611A | Poisoning by thrombolytic drug, accidental (unintentional), initial encounter | ✓ |
| T45.611A | Poisoning by thrombolytic drug, accidental (unintentional), initial encounter | ✓ |
| T45.611D | Poisoning by thrombolytic drug, accidental (unintentional), subsequent encounter | ✓ |
| T45.611D | Poisoning by thrombolytic drug, accidental (unintentional), subsequent encounter | ✓ |
| T45.611S | Poisoning by thrombolytic drug, accidental (unintentional), sequela | ✓ |
| T45.611S | Poisoning by thrombolytic drug, accidental (unintentional), sequela | ✓ |
| T45.612 | Poisoning by thrombolytic drug, intentional self-harm | — |
| T45.612 | Poisoning by thrombolytic drug, intentional self-harm | — |
| T45.612A | Poisoning by thrombolytic drug, intentional self-harm, initial encounter | ✓ |
| T45.612A | Poisoning by thrombolytic drug, intentional self-harm, initial encounter | ✓ |
| T45.612D | Poisoning by thrombolytic drug, intentional self-harm, subsequent encounter | ✓ |
| T45.612D | Poisoning by thrombolytic drug, intentional self-harm, subsequent encounter | ✓ |
| T45.612S | Poisoning by thrombolytic drug, intentional self-harm, sequela | ✓ |
| T45.612S | Poisoning by thrombolytic drug, intentional self-harm, sequela | ✓ |
| T45.613 | Poisoning by thrombolytic drug, assault | — |
| T45.613 | Poisoning by thrombolytic drug, assault | — |
| T45.613A | Poisoning by thrombolytic drug, assault, initial encounter | ✓ |
| T45.613A | Poisoning by thrombolytic drug, assault, initial encounter | ✓ |
| T45.613D | Poisoning by thrombolytic drug, assault, subsequent encounter | ✓ |
| T45.613D | Poisoning by thrombolytic drug, assault, subsequent encounter | ✓ |
| T45.613S | Poisoning by thrombolytic drug, assault, sequela | ✓ |
| T45.613S | Poisoning by thrombolytic drug, assault, sequela | ✓ |
| T45.614 | Poisoning by thrombolytic drug, undetermined | — |
| T45.614 | Poisoning by thrombolytic drug, undetermined | — |
| T45.614A | Poisoning by thrombolytic drug, undetermined, initial encounter | ✓ |
| T45.614A | Poisoning by thrombolytic drug, undetermined, initial encounter | ✓ |
| T45.614D | Poisoning by thrombolytic drug, undetermined, subsequent encounter | ✓ |
| T45.614D | Poisoning by thrombolytic drug, undetermined, subsequent encounter | ✓ |
| T45.614S | Poisoning by thrombolytic drug, undetermined, sequela | ✓ |
| T45.614S | Poisoning by thrombolytic drug, undetermined, sequela | ✓ |
| T45.615 | Adverse effect of thrombolytic drugs | — |
| T45.615 | Adverse effect of thrombolytic drugs | — |
| T45.615A | Adverse effect of thrombolytic drugs, initial encounter | ✓ |
| T45.615A | Adverse effect of thrombolytic drugs, initial encounter | ✓ |
| T45.615D | Adverse effect of thrombolytic drugs, subsequent encounter | ✓ |
| T45.615D | Adverse effect of thrombolytic drugs, subsequent encounter | ✓ |
| T45.615S | Adverse effect of thrombolytic drugs, sequela | ✓ |
| T45.615S | Adverse effect of thrombolytic drugs, sequela | ✓ |
| T45.616 | Underdosing of thrombolytic drugs | — |
| T45.616 | Underdosing of thrombolytic drugs | — |
| T45.616A | Underdosing of thrombolytic drugs, initial encounter | ✓ |
| T45.616A | Underdosing of thrombolytic drugs, initial encounter | ✓ |
| T45.616D | Underdosing of thrombolytic drugs, subsequent encounter | ✓ |
| T45.616D | Underdosing of thrombolytic drugs, subsequent encounter | ✓ |
| T45.616S | Underdosing of thrombolytic drugs, sequela | ✓ |
| T45.616S | Underdosing of thrombolytic drugs, sequela | ✓ |
| T45.621 | Poisoning by hemostatic drug, accidental (unintentional) | — |
| T45.621 | Poisoning by hemostatic drug, accidental (unintentional) | — |
| T45.621A | Poisoning by hemostatic drug, accidental (unintentional), initial encounter | ✓ |
| T45.621A | Poisoning by hemostatic drug, accidental (unintentional), initial encounter | ✓ |
| T45.621D | Poisoning by hemostatic drug, accidental (unintentional), subsequent encounter | ✓ |
| T45.621D | Poisoning by hemostatic drug, accidental (unintentional), subsequent encounter | ✓ |
| T45.621S | Poisoning by hemostatic drug, accidental (unintentional), sequela | ✓ |
| T45.621S | Poisoning by hemostatic drug, accidental (unintentional), sequela | ✓ |
| T45.622 | Poisoning by hemostatic drug, intentional self-harm | — |
| T45.622 | Poisoning by hemostatic drug, intentional self-harm | — |
| T45.622A | Poisoning by hemostatic drug, intentional self-harm, initial encounter | ✓ |
| T45.622A | Poisoning by hemostatic drug, intentional self-harm, initial encounter | ✓ |
| T45.622D | Poisoning by hemostatic drug, intentional self-harm, subsequent encounter | ✓ |
| T45.622D | Poisoning by hemostatic drug, intentional self-harm, subsequent encounter | ✓ |
| T45.622S | Poisoning by hemostatic drug, intentional self-harm, sequela | ✓ |
| T45.622S | Poisoning by hemostatic drug, intentional self-harm, sequela | ✓ |
| T45.623 | Poisoning by hemostatic drug, assault | — |
| T45.623 | Poisoning by hemostatic drug, assault | — |
| T45.623A | Poisoning by hemostatic drug, assault, initial encounter | ✓ |
| T45.623A | Poisoning by hemostatic drug, assault, initial encounter | ✓ |
| T45.623D | Poisoning by hemostatic drug, assault, subsequent encounter | ✓ |
| T45.623D | Poisoning by hemostatic drug, assault, subsequent encounter | ✓ |
| T45.623S | Poisoning by hemostatic drug, assault, sequela | ✓ |
| T45.623S | Poisoning by hemostatic drug, assault, sequela | ✓ |
| T45.624 | Poisoning by hemostatic drug, undetermined | — |
| T45.624 | Poisoning by hemostatic drug, undetermined | — |
| T45.624A | Poisoning by hemostatic drug, undetermined, initial encounter | ✓ |
| T45.624A | Poisoning by hemostatic drug, undetermined, initial encounter | ✓ |
| T45.624D | Poisoning by hemostatic drug, undetermined, subsequent encounter | ✓ |
| T45.624D | Poisoning by hemostatic drug, undetermined, subsequent encounter | ✓ |
| T45.624S | Poisoning by hemostatic drug, undetermined, sequela | ✓ |
| T45.624S | Poisoning by hemostatic drug, undetermined, sequela | ✓ |
| T45.625 | Adverse effect of hemostatic drug | — |
| T45.625 | Adverse effect of hemostatic drug | — |
| T45.625A | Adverse effect of hemostatic drug, initial encounter | ✓ |
| T45.625A | Adverse effect of hemostatic drug, initial encounter | ✓ |
| T45.625D | Adverse effect of hemostatic drug, subsequent encounter | ✓ |
| T45.625D | Adverse effect of hemostatic drug, subsequent encounter | ✓ |
| T45.625S | Adverse effect of hemostatic drug, sequela | ✓ |
| T45.625S | Adverse effect of hemostatic drug, sequela | ✓ |
| T45.626 | Underdosing of hemostatic drugs | — |
| T45.626 | Underdosing of hemostatic drugs | — |
| T45.626A | Underdosing of hemostatic drugs, initial encounter | ✓ |
| T45.626A | Underdosing of hemostatic drugs, initial encounter | ✓ |
| T45.626D | Underdosing of hemostatic drugs, subsequent encounter | ✓ |
| T45.626D | Underdosing of hemostatic drugs, subsequent encounter | ✓ |
| T45.626S | Underdosing of hemostatic drugs, sequela | ✓ |
| T45.626S | Underdosing of hemostatic drugs, sequela | ✓ |
| T45.691 | Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional) | — |
| T45.691 | Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional) | — |
| T45.691A | Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter | ✓ |
| T45.691A | Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter | ✓ |
| T45.691D | Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter | ✓ |
| T45.691D | Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter | ✓ |
| T45.691S | Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), sequela | ✓ |
| T45.691S | Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), sequela | ✓ |
| T45.692 | Poisoning by other fibrinolysis-affecting drugs, intentional self-harm | — |
| T45.692 | Poisoning by other fibrinolysis-affecting drugs, intentional self-harm | — |
| T45.692A | Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter | ✓ |
| T45.692A | Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter | ✓ |
| T45.692D | Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter | ✓ |
| T45.692D | Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter | ✓ |
| T45.692S | Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela | ✓ |
| T45.692S | Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela | ✓ |
| T45.693 | Poisoning by other fibrinolysis-affecting drugs, assault | — |
| T45.693 | Poisoning by other fibrinolysis-affecting drugs, assault | — |
| T45.693A | Poisoning by other fibrinolysis-affecting drugs, assault, initial encounter | ✓ |
| T45.693A | Poisoning by other fibrinolysis-affecting drugs, assault, initial encounter | ✓ |
| T45.693D | Poisoning by other fibrinolysis-affecting drugs, assault, subsequent encounter | ✓ |
| T45.693D | Poisoning by other fibrinolysis-affecting drugs, assault, subsequent encounter | ✓ |
| T45.693S | Poisoning by other fibrinolysis-affecting drugs, assault, sequela | ✓ |
| T45.693S | Poisoning by other fibrinolysis-affecting drugs, assault, sequela | ✓ |
| T45.694 | Poisoning by other fibrinolysis-affecting drugs, undetermined | — |
| T45.694 | Poisoning by other fibrinolysis-affecting drugs, undetermined | — |
| T45.694A | Poisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter | ✓ |
| T45.694A | Poisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter | ✓ |
| T45.694D | Poisoning by other fibrinolysis-affecting drugs, undetermined, subsequent encounter | ✓ |
| T45.694D | Poisoning by other fibrinolysis-affecting drugs, undetermined, subsequent encounter | ✓ |
| T45.694S | Poisoning by other fibrinolysis-affecting drugs, undetermined, sequela | ✓ |
| T45.694S | Poisoning by other fibrinolysis-affecting drugs, undetermined, sequela | ✓ |
| T45.695 | Adverse effect of other fibrinolysis-affecting drugs | — |
| T45.695 | Adverse effect of other fibrinolysis-affecting drugs | — |
| T45.695A | Adverse effect of other fibrinolysis-affecting drugs, initial encounter | ✓ |
| T45.695A | Adverse effect of other fibrinolysis-affecting drugs, initial encounter | ✓ |
| T45.695D | Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter | ✓ |
| T45.695D | Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter | ✓ |
| T45.695S | Adverse effect of other fibrinolysis-affecting drugs, sequela | ✓ |
| T45.695S | Adverse effect of other fibrinolysis-affecting drugs, sequela | ✓ |
| T45.696 | Underdosing of other fibrinolysis-affecting drugs | — |
| T45.696 | Underdosing of other fibrinolysis-affecting drugs | — |
| T45.696A | Underdosing of other fibrinolysis-affecting drugs, initial encounter | ✓ |
| T45.696A | Underdosing of other fibrinolysis-affecting drugs, initial encounter | ✓ |
| T45.696D | Underdosing of other fibrinolysis-affecting drugs, subsequent encounter | ✓ |
| T45.696D | Underdosing of other fibrinolysis-affecting drugs, subsequent encounter | ✓ |
| T45.696S | Underdosing of other fibrinolysis-affecting drugs, sequela | ✓ |
| T45.696S | Underdosing of other fibrinolysis-affecting drugs, sequela | ✓ |
| T45.A | Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs | — |
| T45.A | Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs | — |
| T45.AX | Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs | — |
| T45.AX | Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs | — |
| T45.AX1 | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional) | — |
| T45.AX1 | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional) | — |
| T45.AX1A | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), initial encounter | ✓ |
| T45.AX1A | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), initial encounter | ✓ |
| T45.AX1D | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), subsequent encounter | ✓ |
| T45.AX1D | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), subsequent encounter | ✓ |
| T45.AX1S | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), sequela | ✓ |
| T45.AX1S | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), sequela | ✓ |
| T45.AX2 | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm | — |
| T45.AX2 | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm | — |
| T45.AX2A | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, initial encounter | ✓ |
| T45.AX2A | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, initial encounter | ✓ |
| T45.AX2D | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, subsequent encounter | ✓ |
| T45.AX2D | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, subsequent encounter | ✓ |
| T45.AX2S | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, sequela | ✓ |
| T45.AX2S | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, sequela | ✓ |
| T45.AX3 | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault | — |
| T45.AX3 | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault | — |
| T45.AX3A | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, initial encounter | ✓ |
| T45.AX3A | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, initial encounter | ✓ |
| T45.AX3D | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounter | ✓ |
| T45.AX3D | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounter | ✓ |
| T45.AX3S | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela | ✓ |
| T45.AX3S | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela | ✓ |
| T45.AX4 | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined | — |
| T45.AX4 | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined | — |
| T45.AX4A | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, initial encounter | ✓ |
| T45.AX4A | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, initial encounter | ✓ |
| T45.AX4D | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, subsequent encounter | ✓ |
| T45.AX4D | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, subsequent encounter | ✓ |
| T45.AX4S | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, sequela | ✓ |
| T45.AX4S | Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, sequela | ✓ |
| T45.AX5 | Adverse effect of immune checkpoint inhibitors and immunostimulant drugs | — |
| T45.AX5 | Adverse effect of immune checkpoint inhibitors and immunostimulant drugs | — |
| T45.AX5A | Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter | ✓ |
| T45.AX5A | Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter | ✓ |
| T45.AX5D | Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter | ✓ |
| T45.AX5D | Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter | ✓ |
| T45.AX5S | Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela | ✓ |
| T45.AX5S | Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela | ✓ |
| T45.AX6 | Underdosing of immune checkpoint inhibitors and immunostimulant drugs | — |
| T45.AX6 | Underdosing of immune checkpoint inhibitors and immunostimulant drugs | — |
| T45.AX6A | Underdosing of immune checkpoint inhibitors and immunostimulant drugs, initial encounter | ✓ |
| T45.AX6A | Underdosing of immune checkpoint inhibitors and immunostimulant drugs, initial encounter | ✓ |
| T45.AX6D | Underdosing of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter | ✓ |
| T45.AX6D | Underdosing of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter | ✓ |
| T45.AX6S | Underdosing of immune checkpoint inhibitors and immunostimulant drugs, sequela | ✓ |
| T45.AX6S | Underdosing of immune checkpoint inhibitors and immunostimulant drugs, sequela | ✓ |
Frequently asked questions
What is ICD-10-CM code T45?
T45 is an ICD-10-CM category covering Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified. It contains 770 more specific diagnosis codes, 540 of which are billable.
Is T45 a billable code?
No — T45 is a category header and isn't billable on its own. Code to the highest level of specificity using one of its subcodes (for example T45.0 — Poisoning by, adverse effect of and underdosing of antiallergic and antiemetic drugs). 540 of the 770 codes under T45 are billable.
What codes fall under T45?
T45 includes T45.0, T45.0, T45.0X, T45.0X, T45.0X1, plus 765 more. See the full list with descriptions and billable status above.
More free billing tools: all ICD-10 categories · ICD-10 search · denial codes · Medicare fees
Informational only, not coding or medical advice. Verify against the official ICD-10-CM (FY2026) and your payer's guidelines.
Code the diagnosis right
Join providers across the country delivering modern virtual care with CareNiva. Free to start, ready in minutes.
100% Satisfaction Guaranteed — try it risk-free